COMMUNIQUÉS West-GlobeNewswire

Houston Methodist Selects Tabula Rasa HealthCare’s DoseMe For System-wide Precision Dosing Technology
13/06/2019
MOORESTOWN, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc.’s (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced a multi-year [...]
Entasis Therapeutics Announces Initial ETX0282 Phase 1 Results
13/06/2019
WALTHAM, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company developing novel antibacterials to treat serious drug-resistant infections [...]
iCAD Introduces ProFound AI™ for 2D Mammography in Europe
13/06/2019
Company to showcase its newest artificial intelligence software solution, ProFound AI for 2D Mammography, in addition to ProFound AI for Digital Breast Tomosynthesis at the SIFEM Medical Conference in France NASHUA, N.H [...]
Telix Pharmaceuticals and Eczacıbaşı-Monrol Sign Manufacturing and Distribution Agreement
13/06/2019
MELBOURNE, Australia and ISTANBUL, Turkey, June 13, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Novo Nordisk A/S - Share repurchase programme
13/06/2019
Bagsværd, Denmark, 13 June 2019 - On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants
13/06/2019
Identification of pathogenic structural variants with SMRT Sequencing improves solve rate for rare and Mendelian diseases MENLO PARK, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- While DNA sequencing tools have been useful [...]
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection
13/06/2019
Findings from major health centers to be presented at ASM Microbe 2019 GAITHERSBURG, Md., June 13, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today that data from its Acuitas ® AMR Gene Panel and [...]
Amicus Therapeutics Adds Key Executives in Gene Therapy Science and Global Commercial Leadership
13/06/2019
Jill Weimer, PhD named Senior Vice President of Discovery Research and Gene Therapy Science Simon Jordan named Senior Vice President of International CRANBURY, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics [...]
Stemline Therapeutics Announces Three ELZONRIS (tagraxofusp) Clinical Presentations at EHA Congress June 13-15
13/06/2019
NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]
G1 Therapeutics Announces Updates to Board of Directors
13/06/2019
- Garry Nicholson to serve as new board chair - - Sir Andrew Witty, Fredric Eshelman, Pharm.D. and prior chair Seth Rudnick, M.D. re-elected - RESEARCH TRIANGLE PARK, N.C., June 13, 2019 (GLOBE NEWSWIRE) -- G1 [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/06/2019
WATERTOWN, Mass., June 13, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
CureVac Receives Grants for Three Patents Regarding Intratumoral Application of RNA
13/06/2019
Granted patents cover CureVac’s oncological pipeline regarding intratumoral treatment TÜBINGEN, Germany and BOSTON, June 13, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering [...]
Achillion to Present at the JMP Securities Life Sciences Conference
13/06/2019
BLUE BELL, Pa., June 13, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and Commercialization of Virtue® Sirolimus-Eluting Balloon
13/06/2019
Virtue ® SEB is expected to become a flagship therapeutic product for Terumo and will strengthen its broad US and global portfolio of interventional solutions Terms of the partnership include substantial up-front and [...]
Emerald Health Therapeutics fera une présentation à la conférence Oppenheimer sur la croissance de la consommation et du commerce électronique
13/06/2019
VANCOUVER, Colombie-Britannique, 13 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH; OTCQX: EMHTF), fabricant homologué de produits à base de cannabis à des fins médicales et [...]
iCAD Announces Pricing of Public Offering of Common Stock
13/06/2019
NASHUA, N.H., June 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today the pricing of its [...]
Cambium Networks Corporation Announces Launch of Initial Public Offering
13/06/2019
ROLLING MEADOWS, Ill., June 13, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”), a provider of wireless broadband networking infrastructure solutions, today announced that it has launched the roadshow [...]
Arcturus Therapeutics Announces Redomiciliation to the United States as a Delaware Corporation
13/06/2019
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of [...]
Tonix Pharmaceuticals Announces Issuance of Patent in China for the Composition and Formulation of TNX-102 SL
13/06/2019
Patent Expected to Provide Intellectual Property Protection until 2034 in China NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage [...]

Pages